paul whiteside, m.s., c.e.o. email: whitesidephd@gmail.com alt.: barmanne@gmail.com
Post on 17-Jan-2016
227 Views
Preview:
TRANSCRIPT
Medical Photonics Industries, LLCPaul Whiteside, M.S., C.E.O.
Email: whitesidephd@gmail.comAlt.: barmanne@gmail.com
WaveLazeLaser Dermatology Hand-piece
Market Opportunity& Unmet Clinical Need
Systematic Problems “Point-and-shoot”
paradigm Easy to misuse Inefficient procedures No training required
NPO’s: 64% of litigations ‘04-’12 100% of litigations in 2012 Mean indemnity payment
is $380k1,2
Value Proposition:Efficient, direct transmission
Waveguides: Light transmitted directly into skin No reflections Easier to use Anticipated to be more effective Modular
Stakeholder opinions: Need to prevent accidental firing Ergonomics are important Efficiency is key
Target Market Dynamics
Market dynamics: Total U.S. Market: $800M $46M for consumables alone CAGR: 12% (Frost & Sullivan)
R&D performed by Start-Ups
Annual procedures: (clinics only) 33,363 tattoo removals 1,080,082 hair removal procedures 439,493 skin resurfacings
Medical Spas make up another 30-60% of the market3
Business Model and Market Strategy
Medical Photonics Industries: Keurig-style business model
“Cheap” hand-pieces Frequently purchased consumables
FDA 510(k) Acquisition or partnership
Market Leaders: Syneron Medical: 14 acq, 7 pt, 2 lic Cynosure: 4 acq, 4 dist Palomar: 9 pt, 3 lic Lumenis
Intellectual Property& Proprietary Technology
Intellectual Property: Patent pending through OTMIR (#13UMC079prov) Additional patent disclosures filed
FDA 510(k): Show functional similarity to FDA approved laser devices
Hoya ConBio RevLite (K) 103118 SideLaze800 Laser Beam Accessory (K) 121127
Management Team& Advisory Board
Paul Whiteside
Medical PhotonicsCEO
M.S., Ph.D. StudentPrincipal Inventor
Eric Barmann
Medical PhotonicsCFO
B.S., M.B.A.I.P. expert
John Viator, Ph.D.
Advisory Board
Program DirectorBiomedical Engineering
Duquesne University
Nicholas Golda, M.D.
Advisory Board
Medical DirectorDermatology and Skin Surgery Center, University of Missouri
Michael Flagg, PMP
Advisory Board
FDA Regulatory Expert,MU Research Reactor
Timeline & Milestones
2014 Q2 2015
Q3 2015 Q4 2015 Q1 2016 Q2 2016 2017 2018
Fast Track Funding (MU system grant)
Efficiency Improvement
(I.P. #2)Preclinical Trials
SBIR Application
Waveguide Fabrication
Optimization
In vitroPig Skin Testing
Prototype Fabrication
Expected SBIR Decision
Clinical Trials to follow in SBIR
Phase II
Coulter Seed Funding: Low-energy waveguide
development
Coulter Seed Funding SBIR Phase I, Phase II, Coulter, MTC
Medical Photonics Industries, LLCPaul Whiteside, M.S., C.E.O.
Email: whitesidephd@gmail.comAlt.: barmanne@gmail.com
WaveLazeLaser Dermatology Hand-piece
References
Image 1: www.thetattooeditor.com/laser-tattoo-removal-technique/
Image 2: www.deccanchronicle.com/140702/nation-current-affairs/article/most-indian-laser-clinics-do-not-follow-any-norms
1. H. Ray Jalian, “Increased Risk of Litigation Associated with Laser Surgery by Nonphysician Operators”, JAMA Dermatol. 150(4), 2014
2. H. Ray Jalian, “Common Causes of Injury and Legal Action in Laser Surgery”, JAMA Dermatol., 149(2), 2013
3. Cosmetic Surgery National Data Bank, Statistics 2014 www.surgery.org/sites/default/files/2014-Stats.pdf
top related